Once‐daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post‐hoc analysis of a phase III randomized clinical trial

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 7, 2015-07 ,pp. : 684-688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of the Selective β3‐Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Study

By  

LUTS, Vol. 7, Iss. 2, 2015-05 ,pp. : 84-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of a randomized, double‐blind, parallel‐group, placebo‐ and active‐controlled, multicenter study of mirabegron, a β3‐adrenoceptor agonist, in patients with overactive bladder in Asia

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 34, Iss. 7, 2015-09 ,pp. : 685-692

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial

By Berger William E.   Milgrom Henry   Skoner David P.   Tripp Kenneth   Parsey Merdad V.   Baumgartner Rudolf A.    

Current Medical Research and Opinion, Vol. 22, Iss. 6, 2006-06 ,pp. : 1217-1226

Informa Healthcare

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Efficacy Crossover Trial Comparing Formoterol-HFA (pMDI) versus Formoterol-DPI (Aerolizer^TM) and Placebo (pMDI or Aerolizer^TM) in Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 6-12

Karger

Access to resources Recommend Favorite